Inspire Medical Systems (INSP) Receives New Coverage from Analysts at Leerink Swann

Share on StockTwits

Analysts at Leerink Swann began coverage on shares of Inspire Medical Systems (NASDAQ:INSP) in a research report issued on Monday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $57.00 price target on the stock. Leerink Swann’s target price points to a potential upside of 45.78% from the company’s previous close.

Separately, Zacks Investment Research cut Inspire Medical Systems from a “hold” rating to a “sell” rating in a research note on Thursday, September 27th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $40.86.

INSP opened at $39.10 on Monday. Inspire Medical Systems has a 52 week low of $22.50 and a 52 week high of $57.87.

Inspire Medical Systems (NASDAQ:INSP) last announced its quarterly earnings data on Tuesday, August 7th. The company reported ($0.43) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.51) by $0.08. The company had revenue of $10.94 million for the quarter, compared to analysts’ expectations of $9.30 million.

Large investors have recently made changes to their positions in the business. Valeo Financial Advisors LLC purchased a new position in Inspire Medical Systems during the second quarter valued at $229,000. Rhumbline Advisers purchased a new position in Inspire Medical Systems during the second quarter valued at $243,000. Bank of America Corp DE purchased a new position in Inspire Medical Systems during the second quarter valued at $306,000. Dean Capital Investments Management LLC purchased a new position in Inspire Medical Systems during the second quarter valued at $857,000. Finally, Wasatch Advisors Inc. purchased a new position in Inspire Medical Systems during the second quarter valued at $1,065,000.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Read More: What is a Fiduciary?

Analyst Recommendations for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply